Amarin And Neopharm Announce Exclusive Commercialization Agr

Amarin And Neopharm Announce Exclusive Commercialization Agreement For Vazkepa® (Icosapent Ethyl) In Israel

Amarin And Neopharm Announce Exclusive Commercialization Agreement For Vazkepa® (Icosapent Ethyl) In Israel

menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Ireland , Finland , Gaza , Israel General , Israel , Austria , United Kingdom , United Arab Emirates , United States , Sweden , Switzerland , Dublin , New Jersey , Bridgewater , Nova Scotia , Canada , Lebanon , West Bank , Denmark , State Of Israel , Palestinian , Israeli , Great Britain , Scotland , Patrick Holt , Steven Ketchum , Mark Marmur , Amarin Neopharm , Research Development , Israeli Ministry Of Health , Exchange Commission , Amarin Corporation , European Union , Israel Ministry Of Health , Palestinian Authority , Pharmaceuticals Division , Nasdaq , Health Information Division , Follows Recent Regulatory Approval , Adult Statin Treated Patients , Elevated Triglycerides , Disease Second Leading Cause , Women Aged , Neopharm Israel , Efi Shnaidman , General Manager , Israeli Ministry , Chief Scientific Officer , Regulatory Approvals , Marketing Authorization Holder , Private Securities Litigation Reform Act , Securities Act , Accessed August , Health Information ,